
Advertise on podcast: AtheroTalk
Rating
4from
This podcast has
41 episodes
Language
EnglishPublisher
European Atherosclerosis SocietyExplicit
No
Date created
2024/11/18
Latest episode
2026/10/27
Average duration
34 min.
Release period
20 days
Description
AtheroTalk is your go-to podcast for in-depth discussions on atherosclerosis and cardiovascular health. Join leading experts as they explore the latest research, breakthrough treatments, and real-world insights into preventing and managing heart disease. Whether you're a healthcare professional, researcher, or just passionate about heart health, AtheroTalk delivers valuable knowledge and practical tips straight from the experts. Tune in to stay informed and inspired about the future of cardiovascular care! -------------------------- This podcast is proudly initiated by the EAS Young Fellows.
Unlock AtheroTalk podcast Email contact info,
Listeners & Audience details
Email contact information
Direct podcast contact details

Listeners
Audience numbers & engagement insights

Audience details
Podcast Insights

Podcast episodes
Check latest episodes from AtheroTalk podcast
E41: Nabil Seidah & Marianne Abi Fadel
2026/10/27
In this episode of AtheroTalk, we meet two pioneers of the PCSK9 story, Prof. Nabil Seidah and Prof. Marianne Abi Fadel. They take us through the discoveries that transformed our understanding of PCSK9 and familial hypercholesterolaemia - from genetic discovery and basic science to therapies that have changed cardiovascular care - while sharing personal reflections on collaboration and the future of lipidology.
---------------------------------------------------
Script-prep: Fotios Barkas, Azin Kheirkhah
Interviewer: Fotios Barkas, Azin Kheirkhah
E40: Patrick Rensen
2026/10/13
In this episode of AtheroTalk, we are delighted to host Prof. Patrick C. N. Rensen from Leiden University Medical Center, Professor of Endocrinology and a leading researcher in cardiometabolic science. His work focuses on inter-organ crosstalk in glucose and lipid metabolism and its implications for cardiovascular and metabolic disease.
By listening to Prof. Rensen’s scientific journey and translational perspective, we explore how experimental models can help us better understand cardiometabolic disease, from the APOE*3-Leiden.CETP mouse model to emerging heart-on-chip technologies. We also discuss the fascinating role of brown adipose tissue in human cardiometabolic health, strategies to enhance its function, and some of the common misconceptions surrounding it.
The conversation further takes us into the interplay between circadian rhythms and metabolism, as well as the translational potential of ongoing clinical studies such as CoolBAT and TikTac. Beyond science, Prof. Rensen also shares his perspective on teaching, scientific communication, and the lessons that can be learned from ideas and projects that do not always go as planned.
—————————————————
Script-prep: Hana Bartuskova
Interviewer: Yusuf Ziya Sener
E39: Katariina Öörni
2026/09/29
Prof. Katariina Öörni, Co-Editor of Atherosclerosis, the official journal of the EAS and a member of the EAS Executive Committee for Communication in 2025-2028, is our distinguished guest in this episode of AtheroTalk.
The conversation paints us a vivid picture about Prof. Öörni’s academic journey and research and is full of inspiring stories. Tune in to hear more about the function of lipoprotein particles and their role in atherosclerosis development, the Atherosclerosis Research Laboratory in the Wihuri Research Institute, the Finnish lifestyle that promotes cardiovascular health, very unusual research subjects and brilliant advice for young clinicians and researchers.
---------------------------------------------------
Script-prep: Hana Bartušková
Interviewer: Laura Gaita
E38: Heribert Schunkert
2026/09/08
In this episode of AtheroTalk we are privileged to host Prof. Heribert Schunkert, the recipient of the 2026 EAS Anitschkow Prize - the Society’s most prestigious award - for his pioneering work in the genetics of atherosclerosis and cardiovascular disease.
By listening to Prof. Schunkert’s inspiring academic journey and thought-provoking insights regarding the future of cardiovascular disease management, this discussion makes us wonder about how we can include polygenic risk scores in daily clinical practice, how we can improve the care of our patients with familial hypercholesterolemia and about how we can overcome the biggest challenges in cardiometabolic medicine.
---------------------------------------------------
Script-prep: Laura Gaita, Azin Kheirkhah, Tatyana Storozhenko
Interviewer: Laura Gaita
E37: Soheil Saeedi, Cesare Canepari & Berkan Kurt
2026/08/24
How do we beat atherosclerosis? In this special EAS Stage session, we bring together three rising scientists tackling that single question from completely different angles. Dr Soheil Saeedi (University of Zurich) explores cardiovascular aging and how a gut microbial metabolite can drive endothelial senescence. Dr Cesare Canepari (San Raffaele Telethon Institute for Gene Therapy) makes the case for gene therapy and genome editing to actually cure familial hypercholesterolemia. Dr Berkan Kurt (University Hospital Aachen) brings the clinician-scientist's perspective on inflammation, hsCRP, and emerging biomarkers, straight from the bedside. Three labs, three countries, three toolkits, one disease.
---------------------------------------------------
Script-prep: Pelin Golforoush, Tatyana Storozhenko
Interviewer: Pelin Golforoush, Tatyana Storozhenko
E36: Manuel Mayr
2026/07/27
In this episode of AtheroTalk, we sit down with Prof. Manuel Mayr to explore how proteomics, multi-omics, and systems biology are transforming the way we understand cardiovascular disease. From decoding complex molecular networks to discussing the future of AI-driven medicine, Prof. Mayr shares a fascinating perspective on the evolving landscape of cardiovascular research and the challenges of translating massive datasets into meaningful clinical insight. Beyond the science, the conversation reflects on curiosity, mentorship, and building a career driven by genuine passion.
---------------------------------------------------
Script-prep: Pelin Golforoush
Interviewer: Pelin Golforoush
E35: Dagmar Kratky
2026/06/16
Prof. Dagmar Kratky is often called the “queen of lipid hydrolases” — and in this episode of AtheroTalk, she shares her passion for this fascinating field. Discover how cells store and mobilize fat, why maintaining the balance between these processes is essential for metabolic health, and which lipid hydrolases still remain to be discovered. Beyond the science, Dagmar Kratky also shares personal insights into the key milestones of her career and offers inspiring advice for young scientists: “Stay persistent, try again, never give up, and never take it personally — just try again, and it will work.” An inspiring conversation about scientific curiosity, resilience, and the future of lipid research.
---------------------------------------------------
Script-prep: Azin Kheirkhah
Interviewer: Marion Mussbacher
E34: Zanfina Ademi
2026/06/02
What does it take to turn scientific evidence into healthcare policy that improves lives? In this AtheroTalk episode, we sit down with Prof. Zanfina Ademi, a leading health economist at Monash University, to explore how health economics shapes modern cardiovascular prevention. From the development of Productivity-Adjusted Life Years (PALYs) to the global push for lipoprotein(a) testing, Prof. Ademi shares insights from her remarkable career at the intersection of science, policy, and public health. Join us for an inspiring conversation about innovation, impact, and the future of cardiovascular care.
---------------------------------------------------
Script-prep: Azin Kheirkhah
Interviewer: Azin Kheirkhah
E33: Raul Santos
2026/05/19
This episode of AtheroTalk features Prof. Raul Santos from Brazil, reflecting on his journey in cardiovascular medicine and his impact on the field of lipidology. The discussion covers advances in familial hypercholesterolemia, LDL lowering, and emerging therapies like Lp(a), alongside the real-world challenges of prevention across different regions. Combining scientific insight with personal perspective, it’s an engaging and thoughtful conversation with a clear message: stay curious, keep pushing forward, and “go after your dreams”.
---------------------------------------------------
Script-prep: Pelin Golforoush
Interviewer: Pelin Golforoush
E32: Pablo Corral
2026/05/05
What does it take to build a career at the intersection of clinical care, research, and global collaboration? In this episode of AtheroTalk, we speak with Prof. Pablo Corral from Argentina, who brings a grounded and insightful perspective on lipid disorders, cardiovascular prevention, and the evolving role of large-scale clinical trials.
From tackling familial hypercholesterolemia to addressing residual risk, he shares both the realities and possibilities of advancing care in Latin America. Along the way, he reflects on mentorship, career choices, and what truly sustains long-term motivation, captured in one simple idea: “Find something you are truly passionate about.”
A thoughtful conversation for anyone navigating science, medicine, and purpose.
---------------------------------------------------
Script-prep: Pelin Golforoush
Interviewer: Pelin Golforoush
E31: Rory Collins
2026/04/21
In this episode, Prof. Rory Collins shares the personal moments that shaped his career and pulls back the curtain on UK Biobank: how it really works, the tough calls, and the surprises along the way. As more of us rely on UKB for our research, this candid conversation is a must-listen for anyone using the resource: the context, trade-offs, and behind-the-scenes details you don’t usually get.
---------------------------------------------------
Script-prep: Hana Bartuskova, Azin Kheirkhah, Elena Rodriguez-Sanchez
Interviewer: Alexandr Ceasovschih, Azin Kheirkhah
E30: Magdalena Daccord
2026/04/07
This interview features Magdalena Daccord, CEO of FH Europe Foundation, discussing key challenges and future directions in the management of familial hypercholesterolemia (FH). The conversation focuses on patient advocacy, early diagnosis, and the importance of international collaboration between clinicians, researchers, and policymakers. Special attention is given to emerging initiatives, including the Lp(a) International Task Force, and the role of patient networks in improving awareness and access to care.
---------------------------------------------------
Script-prep: Maria Cherska, Azin Kheirkhah, Svetlana Stoica
Interviewer: Maria Cherska, Svetlana Stoica
E29: John J.P. Kastelein
2026/03/19
In this episode of AtheroTalk, we are honored to host Prof. John J.P. Kastelein, one of the most influential figures in lipidology and cardiovascular prevention.
With a career spanning decades of groundbreaking research and innovation, Prof. Kastelein shares his personal journey and reflects on the evolution of lipid-lowering therapy — from the early days of statins to today’s rapidly expanding pipeline of novel therapeutics.
Together, we explore the milestones that have shaped modern cardiovascular prevention, the lessons learned along the way, and the exciting future of precision lipid management. This conversation offers unique insights into the intersection of science, clinical practice, and drug development, from someone who has been at the forefront of it all.
---------------------------------------------------
Script-prep: Fotis Barkas
Interviewer: Fotis Barkas
E28: Rodrigo Alonso Karlezi
2026/02/12
In this special global episode of AtheroTalk, the EAS Young Fellows move beyond their traditionally Europe-focused conversations to connect with Professor Rodrigo Alonso Karlezi in Chile, bringing a Latin American perspective to cardiovascular science. The discussion explores international advances in familial hypercholesterolaemia, and the power of international collaboration, while also addressing challenges faced in Latin America such as limited resources, differences in guidelines, and the need to build sustainable research networks. Reflecting on perseverance in global science, Prof. Karlezi reminds us that “no doesn’t mean ‘no’, it means ‘not yet’.”
---------------------------------------------------
Script-prep: Pelin Golforoush
Interviewer: Pelin Golforoush
E27: Gerald Watts
2026/02/02
In this episode of AtheroTalk, we discuss with Prof. Gerald F. Watts, a leading world expert in the field of Familial Hypercholesterolemia (FH) and Cardio-metabolic Medicine, about his professional journey, about national strategies and policies in FH and about how can young professionals achieve a successful career.
Prof. Watts shares his insights about the process of adding clinical meaning into research projects, his mentors and overcoming challenges. He also shares ways to address gaps in care, a fresh perspective on cardiometabolic prevention, methods of thinking and ideas that help researchers keep their research relevant.
Tune in and don’t miss the powerful motto that Prof. Watts has followed throughout his exceptional career – “discovery comes to the prepared mind”.
---------------------------------------------------
Script-prep: Laura Gaita, Maria Giovanna Lupo
Interviewer: Laura Gaita
Podcast sponsorship advertising
Start advertising on AtheroTalk relevant audience podcasts
You may also like to advertise on these Podcasts

4.639655
Only Murders in the Building Podcast
Straw Hut Media

4.7833521
The Home Service Expert Podcast
Tommy Mello: $200 Million Founder|Forbes, Inc., Entrepreneur Columnist

4.443671371
Something You Should Know
Mike Carruthers | OmniCast Media

4.7906254
Everything is Fine
Jennifer Romolini and Kim France

4.610916582
Serialously with Annie Elise
Annie Elise & Audioboom Studios

4.41171483
The Outlier Health Podcast
Matt Frazier, Matt Tullman, Isabelle Caputo, and Doug Hay

4.616224366
Giggly Squad
Hannah Berner & Paige DeSorbo

4.8219787
Imperfect Action
Steph Taylor

4.727637592
This Past Weekend w/ Theo Von
Theo Von

4.713055379
The Tim Dillon Show
The Tim Dillon Show